Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Clinical trial NCT00887809 · COMPLETED

Trial details

NCT number: NCT00887809
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcoma Leiomyosarcoma Malignant Fibrous Histiocytoma Angiosarcoma

Start date: 2009-04-01
Primary completion: 2014-10-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.